{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T04:14:29Z","timestamp":1783311269840,"version":"3.54.6"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,5]]},"DOI":"10.7759\/cureus.112111","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T03:26:02Z","timestamp":1783308362000},"source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and Safety of Hopantenic Acid in Pediatric Neurological and Developmental Disorders: A Systematic Review and Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Prashant R","family":"Uttage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demudu Babu","family":"Boddu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subrat K","family":"Majhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davidson","family":"Devasia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudip","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shikhar","family":"Patanjali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suneel","family":"Godbole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil K","family":"Agarwalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akanksha","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2020.22.1\/macrocq","article-title":"Neurodevelopmental disorders - the history and future of a diagnostic concept","volume":"22","author":"Morris-Rosendahl DJ","year":"2020","unstructured":"Morris-Rosendahl DJ, Crocq MA. Neurodevelopmental disorders - the history and future of a diagnostic concept. Dialogues Clin Neurosci. 2020, 22:65-72. 10.31887\/DCNS.2020.22.1\/macrocq","journal-title":"Dialogues Clin Neurosci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0000000000000042","article-title":"New classification for neurodevelopmental disorders in DSM-5","volume":"27","author":"Harris JC","year":"2014","unstructured":"Harris JC. New classification for neurodevelopmental disorders in DSM-5. Curr Opin Psychiatry. 2014, 27:95-7. 10.1097\/YCO.0000000000000042","journal-title":"Curr Opin Psychiatry"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1080\/20473869.2025.2581660","article-title":"Global trends in developmental disabilities in children and adolescents 1990-2021: sex- and sociodemographic index-stratified analysis of Global Burden of Disease 2021","author":"Xie Y","year":"2025","unstructured":"Xie Y, Shao Y, Li Y, et al.. Global trends in developmental disabilities in children and adolescents 1990-2021: sex- and sociodemographic index-stratified analysis of Global Burden of Disease 2021. Int J Dev Disabil. 2025, 1-16. 10.1080\/20473869.2025.2581660","journal-title":"Int J Dev Disabil"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/09727531231176122","article-title":"Neuroscience engagement and outreach on neurodevelopmental disorders: a report from India","volume":"30","author":"Bhatia D","year":"2023","unstructured":"Bhatia D. Neuroscience engagement and outreach on neurodevelopmental disorders: a report from India. Ann Neurosci. 2023, 30:119-23. 10.1177\/09727531231176122","journal-title":"Ann Neurosci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.887796","article-title":"Study on the economic burden of neurodevelopmental diseases on patients with genetic diagnosis","volume":"10","author":"Xie D","year":"2022","unstructured":"Xie D, Duan R, Li C, et al.. Study on the economic burden of neurodevelopmental diseases on patients with genetic diagnosis. Front Public Health. 2022, 10:10.3389\/fpubh.2022.887796","journal-title":"Front Public Health"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-022-01370-w","article-title":"Synaptic plasticity and mental health: methods, challenges and opportunities","volume":"48","author":"Appelbaum LG","year":"2023","unstructured":"Appelbaum LG, Shenasa MA, Stolz L, Daskalakis Z. Synaptic plasticity and mental health: methods, challenges and opportunities. Neuropsychopharmacology. 2023, 48:113-20. 10.1038\/s41386-022-01370-w","journal-title":"Neuropsychopharmacology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1973.sp010273","article-title":"Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path","volume":"232","author":"Bliss TV","year":"1973","unstructured":"Bliss TV, L\u00f8mo T. Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J Physiol. 1973, 232:331-56. 10.1113\/jphysiol.1973.sp010273","journal-title":"J Physiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fnsyn.2025.1656759","article-title":"GABA(B) receptors negatively modulate excitatory plasticity at the mossy fiber synapse onto parvalbumin-expressing basket and axo-axonic cells in the dentate gyrus","volume":"17","author":"Loureiro RM","year":"2025","unstructured":"Loureiro RM, Booker SA, Kulik A, Vida I. GABA(B) receptors negatively modulate excitatory plasticity at the mossy fiber synapse onto parvalbumin-expressing basket and axo-axonic cells in the dentate gyrus. Front Synaptic Neurosci. 2025, 17:10.3389\/fnsyn.2025.1656759","journal-title":"Front Synaptic Neurosci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2020.03.011","article-title":"GABA(B) receptors: modulation of thalamocortical dynamics and synaptic plasticity","volume":"456","author":"Sanchez-Vives MV","year":"2021","unstructured":"Sanchez-Vives MV, Barbero-Castillo A, Perez-Zabalza M, Reig R. GABA(B) receptors: modulation of thalamocortical dynamics and synaptic plasticity. Neuroscience. 2021, 456:131-42. 10.1016\/j.neuroscience.2020.03.011","journal-title":"Neuroscience"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2022.936392","article-title":"Profiles and correlates of language and social communication differences among young autistic children","volume":"13","author":"Reetzke R","year":"2022","unstructured":"Reetzke R, Singh V, Hong JS, et al.. Profiles and correlates of language and social communication differences among young autistic children. Front Psychol. 2022, 13:10.3389\/fpsyg.2022.936392","journal-title":"Front Psychol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro20151155261-71","article-title":"Neurotropic, anti-inflammatory and antitumor properties of hopantenic acid: a chemoinformatic analysis of its molecule. [Article in Russian]","volume":"115","author":"Gromova OA","year":"2015","unstructured":"Gromova OA, Troshin IY, Limanova OA, Gromov AN, Fedotova LE, Rudakov KV. Neurotropic, anti-inflammatory and antitumor properties of hopantenic acid: a chemoinformatic analysis of its molecule. [Article in Russian]. Zh Nevrol Psikhiatr Im S S Korsakova. 2015, 115:61-71. 10.17116\/jnevro20151155261-71","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1021\/acschembio.1c00535","article-title":"The coenzyme A level modulator hopantenate (HoPan) inhibits phosphopantotenoylcysteine synthetase activity","volume":"16","author":"Mostert KJ","year":"2021","unstructured":"Mostert KJ, Sharma N, van der Zwaag M, et al.. The coenzyme A level modulator hopantenate (HoPan) inhibits phosphopantotenoylcysteine synthetase activity. ACS Chem Biol. 2021, 16:2401-14. 10.1021\/acschembio.1c00535","journal-title":"ACS Chem Biol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2013.01.018","article-title":"Comparison of the effects of the GABAB receptor positive modulator BHF177 and the GABAB receptor agonist baclofen on anxiety-like behavior, learning, and memory in mice","volume":"70","author":"Li X","year":"2012","unstructured":"Li X, Risbrough VB, Cates-Gatto C, Kaczanowska K, Finn MG, Roberts AJ, Markou A. Comparison of the effects of the GABAB receptor positive modulator BHF177 and the GABAB receptor agonist baclofen on anxiety-like behavior, learning, and memory in mice. Neuropharmacology. 2012, 70:156-67. 10.1016\/j.neuropharm.2013.01.018","journal-title":"Neuropharmacology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.20953\/1817-7646-2018-3-61-65","article-title":"Study of the effectiveness of using hopantenic acid in treatment of functional asthenia in children primary school age","volume":"13","author":"Chutko LS","year":"2018","unstructured":"Chutko LS, Surushkina SY, Yakovenko EA, Anisimova TI, Volov MB. Study of the effectiveness of using hopantenic acid in treatment of functional asthenia in children primary school age. Voprosy Prakticheskoi Pediatrii. 2018, 13:61-5. 10.20953\/1817-7646-2018-3-61-65","journal-title":"Voprosy Prakticheskoi Pediatrii"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro201711781132-139","article-title":"Pharmacological effects and clinical application of pantogam and pantogam active. [Article in Russian]","volume":"117","author":"Voronina TA","year":"2017","unstructured":"Voronina TA, Litvinova SA. Pharmacological effects and clinical application of pantogam and pantogam active. [Article in Russian]. Zh Nevrol Psikhiatr Im S S Korsakova. 2017, 117:132-9. 10.17116\/jnevro201711781132-139","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro202212205169","article-title":"Modern application possibilities hopanthenic acid (pantocalcin) in treatmentdiseases of the nervous system in children. [Article in Russian]","volume":"122","author":"Nemkova SA","year":"2022","unstructured":"Nemkova SA. Modern application possibilities hopanthenic acid (pantocalcin) in treatmentdiseases of the nervous system in children. [Article in Russian]. Zh Nevrol Psikhiatr Im S S Korsakova. 2022, 122:69-77. 10.17116\/jnevro202212205169","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne JA","year":"2019","unstructured":"Sterne JA, Savovi\u0107 J, Page MJ, et al.. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019, 366:10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang A","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010, 25:603-5. 10.1007\/s10654-010-9491-z","journal-title":"Eur J Epidemiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s11055-018-0705-2","article-title":"Pharmacotherapy of attention deficit hyperactivity disorder in children: results of a multicenter, double-blind, placebo-controlled trial of hopantenic acid","volume":"49","author":"Zavadenko NN","year":"2019","unstructured":"Zavadenko NN, Suvorinova NY, Vakula IN, et al.. Pharmacotherapy of attention deficit hyperactivity disorder in children: results of a multicenter, double-blind, placebo-controlled trial of hopantenic acid. Neurosci Behav Physi. 2019, 49:129-35. 10.1007\/s11055-018-0705-2","journal-title":"Neurosci Behav Physi"},{"key":"ref20","article-title":"Efficacy and tolerability of pantogam activ in patients with partial epilepsy. [Article in Russian]","volume":"111","author":"Poverennova IE","year":"2011","unstructured":"Poverennova IE, Iakunina AV, Kalinin VA, Savel'eva NN. Efficacy and tolerability of pantogam activ in patients with partial epilepsy. [Article in Russian]. Zh Nevrol Psikhiatr Im S S Korsakova. 2011, 111:54-9.","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro201911910130","article-title":"Pharmacotherapy of psychomotor developmental delay in 6-12 months preterm infants with hypoxic-ischemic encephalopathy (the double-blind comparative multicenter placebo-controlled study). [Article in Russian]","volume":"119","author":"Zavadenko NN","year":"2019","unstructured":"Zavadenko NN, Guzeva VI, Gaynetdinova DD, Davydova LA, Zavadenko AN, Romanova TA. Pharmacotherapy of psychomotor developmental delay in 6-12 months preterm infants with hypoxic-ischemic encephalopathy (the double-blind comparative multicenter placebo-controlled study). [Article in Russian]. Zh Nevrol Psikhiatr Im S S Korsakova. 2019, 119:30-9. 10.17116\/jnevro201911910130","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"key":"ref22","article-title":"Management of cognitive impairment in children and adolescents with cerebral palsy treated with pantocalcin. [Article in Russian]","volume":"113","author":"Batysheva TT","year":"2013","unstructured":"Batysheva TT, Platonova AN, Chebanenko NV, Bykova OV. Management of cognitive impairment in children and adolescents with cerebral palsy treated with pantocalcin. [Article in Russian]. Zh Nevrol Psikhiatr Im S S Korsakova. 2013, 113:48-53.","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro201511510151-55","article-title":"Diagnosis and correction of cognitive impairment in preschool age children with epilepsy. [Article in Russian]","volume":"115","author":"Guzeva VI","year":"2015","unstructured":"Guzeva VI, Guzeva VV, Guzeva OV, Okhrim IV, Zgoda VN. Diagnosis and correction of cognitive impairment in preschool age children with epilepsy. [Article in Russian]. Zh Nevrol Psikhiatr Im S S Korsakova. 2015, 115:51-5. 10.17116\/jnevro201511510151-55","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro20161168174-76","article-title":"The use of pantogam syrup in treating small children's breath holding spells. [Article in Russian]","volume":"116","author":"Polskaya AV","year":"2016","unstructured":"Polskaya AV, Chutko LS, Jakovenko EV. The use of pantogam syrup in treating small children's breath holding spells. [Article in Russian]. Zh Nevrol Psikhiatr Im S S Korsakova. 2016, 116:74-6. 10.17116\/jnevro20161168174-76","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1021\/jm5018913","article-title":"Activation of the \u03b3-aminobutyric acid type B (GABA(B)) receptor by agonists and positive allosteric modulators","volume":"58","author":"Brown KM","year":"2015","unstructured":"Brown KM, Roy KK, Hockerman GH, Doerksen RJ, Colby DA. Activation of the \u03b3-aminobutyric acid type B (GABA(B)) receptor by agonists and positive allosteric modulators. J Med Chem. 2015, 58:6336-47. 10.1021\/jm5018913","journal-title":"J Med Chem"},{"key":"ref26","article-title":"Presynaptic GABA(B) receptors inhibit synaptic inputs to rat subthalamic neurons","volume":"108","author":"Shen KZ","year":"2001","unstructured":"Shen KZ, Johnson SW. Presynaptic GABA(B) receptors inhibit synaptic inputs to rat subthalamic neurons. Neuroscience. 2001, 108:431-6.","journal-title":"Neuroscience"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/349609a0","article-title":"GABAB autoreceptors regulate the induction of LTP","volume":"349","author":"Davies CH","year":"1991","unstructured":"Davies CH, Starkey SJ, Pozza MF, Collingridge GL. GABAB autoreceptors regulate the induction of LTP. Nature. 1991, 349:609-11. 10.1038\/349609a0","journal-title":"Nature"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1134\/s1819712423020198","article-title":"Cognitive impairment and nootropic drugs: mechanism of action and spectrum of effects","volume":"17","author":"Voronina TA","year":"2023","unstructured":"Voronina TA. Cognitive impairment and nootropic drugs: mechanism of action and spectrum of effects. Neurochem J. 2023, 17:180-8. 10.1134\/s1819712423020198","journal-title":"Neurochem J"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1017\/9781108235433.021","article-title":"Assessment of childhood neurodevelopmental disorders","author":"Williams L","year":"2019","unstructured":"Williams L, Sandercock R, Klinger LG. Assessment of childhood neurodevelopmental disorders. The Cambridge Handbook of Clinical Assessment and Diagnosis. Sellbom M, Suhr JA (ed): Cambridge University Press, Cambridge, UK; 2019. 293-307. 10.1017\/9781108235433.021"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.2165\/11539440-000000000-00000","article-title":"Efficacy of methylphenidate for adults with attention-deficit hyperactivity disorder: a meta-regression analysis","volume":"25","author":"Castells X","year":"2011","unstructured":"Castells X, Ramos-Quiroga JA, Rigau D, Bosch R, Nogueira M, Vidal X, Casas M. Efficacy of methylphenidate for adults with attention-deficit hyperactivity disorder: a meta-regression analysis. CNS Drugs. 2011, 25:157-69. 10.2165\/11539440-000000000-00000","journal-title":"CNS Drugs"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(19)30482-1","article-title":"Disparate regulatory status of methylphenidate for adults with ADHD across Europe","volume":"7","author":"Chappuy M","year":"2020","unstructured":"Chappuy M, Boulanger A, Nourredine M, Fourneret P, Rolland B. Disparate regulatory status of methylphenidate for adults with ADHD across Europe. Lancet Psychiatry. 2020, 7:1-2. 10.1016\/S2215-0366(19)30482-1","journal-title":"Lancet Psychiatry"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2622310","article-title":"A review on recent advances of cerebral palsy","volume":"2022","author":"Paul S","year":"2022","unstructured":"Paul S, Nahar A, Bhagawati M, Kunwar AJ. A review on recent advances of cerebral palsy. Oxid Med Cell Longev. 2022, 2022:10.1155\/2022\/2622310","journal-title":"Oxid Med Cell Longev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/502459-efficacy-and-safety-of-hopantenic-acid-in-pediatric-neurological-and-developmental-disorders-a-systematic-review-and-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T03:26:04Z","timestamp":1783308364000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/502459-efficacy-and-safety-of-hopantenic-acid-in-pediatric-neurological-and-developmental-disorders-a-systematic-review-and-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,5]]},"references-count":32,"URL":"https:\/\/doi.org\/10.7759\/cureus.112111","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,5]]}}}